MA23.01 Phase II Trial of an Oral FGFR Inhibitor AZD4547 as Second or Third Line Therapy in Malignant Pleural Mesothelioma: Final Results of FRAME Study
- Resource Type
- Abstract
- Source
- In
Journal of Thoracic Oncology October 2019 14(10) Supplement:S342-S342 - Subject
- Language
- ISSN
- 1556-0864